Daniel Keebler

Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models

Daniel Keebler, Paul Revill, R. Scott Braithwaite et al. · The Lancet Global Health · 2013 · 47 citations · Full text

Pharmacy, Health Policy, Pharmacoeconomics +17

Descriptive epidemiology of 16,780 hospitalized COVID-19 patients in the United States

Devika Chawla, Shemra Rizzo, Kelly A. Zalocusky et al. · medRxiv · 2020 · 39 citations · Full text

Computing, Health Informatics, Infectious Diseases +13

Using modeling to inform international guidelines for antiretroviral treatment

Timothy B. Hallett, Nicolas A. Menzies, Paul Revill et al. · AIDS · 2014 · 30 citations

Public Health, Pharmacoeconomics, Pharmacotherapy +17

How do different eligibility guidelines for antiretroviral therapy affect the cost–effectiveness of routine viral load testing in sub-Saharan Africa?

R. Scott Braithwaite, Kimberly A. Nucifora, Christopher Toohey et al. · AIDS · 2014 · 23 citations

Public Health, Infectious Diseases, Pharmacoeconomics +17

Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials

Daniel Keebler, Edmond Teng, Jenny Chia et al. · Lara D. Veeken · 2020 · 16 citations · Full text

Medicine, Health Sciences, Clinical Epidemiology +16